Strategy & Consulting

Today, the treatment of multiple myeloma has never been so opportunistic, yet so complicated. With 30+ approved drugs, treatments and advanced diagnostic and prognostic testing.

Myeloma is a complicated disease to accurately diagnose and treat. Drug development in myeloma is increasingly challenging and requires expert insights to best navigate a successful development plan.

STRATEGY & CONSULTING

We Provide Strategy, Expert Insights and Advice

Our team is made up of experiences biopharmaceuticals professionals. We have experience managing international programs with the leading experts clinical development, diagnostics and the treatment and management of patients with myeloma.

w

KEY CUSTOMER ENGAGEMENT

  • Key Opinion Leader Strategy, Identification and Engagement
  • Advisory Board Strategy, Planning and Execution
  • Investigator Meetings
  • Round Tables
  • Congress Receptions

CLINICAL DEVELOPMENT

  • Lifecycle Strategy, Creation and Execution
  • Competitive Intelligence and Therapeutic Landscape Monitoring
  • Enrollment Acceleration Strategies

MEDICAL CONFERENCES

  • Congress Strategy
  • Congress Planning
  • Congress Coverage
  • Exhibit Design
  • Content Development
  • Medical Education Strategy and Execution

EVIDENCE GENERATION

  • IST Program Development and Execution
  • HEOR and Real World Evidence Strategy
  • Expanded Access Programs

EXPERT CONSULTANTS FOR PRODUCT DEVELOPMENT

  • Our experienced consultants will work with you to develop a solid business strategy that aligns with your goals and objectives.
  • We’ll help you identify opportunities for innovation to keep your initiatives ‘TOP OF MIND’

MEDICAL AND SCIENTIFIC AFFAIRS

  • Our experienced consultants will work with you to develop a solid business strategy that aligns with your goals and objectives.
  • We’ll help you identify opportunities for innovation to keep your initiatives ‘TOP OF MIND’

Email

info@myeloma360.com